Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction.

Duan W, Ross CA.

Curr Drug Targets. 2010 Oct;11(10):1281-92. Review.

PMID:
20840070
3.

Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research.

Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN.

Carcinogenesis. 2010 Jan;31(1):83-9. doi: 10.1093/carcin/bgp280. Epub 2009 Dec 7. Review.

PMID:
19969554
4.

SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications.

Kume S, Uzu T, Kashiwagi A, Koya D.

Endocr Metab Immune Disord Drug Targets. 2010 Mar;10(1):16-24. Review.

PMID:
20044906
5.

Sirtuins: common targets in aging and in neurodegeneration.

de Oliveira RM, Pais TF, Outeiro TF.

Curr Drug Targets. 2010 Oct;11(10):1270-80. Review.

PMID:
20840069
6.

Glycolytic inhibition as a strategy for developing calorie restriction mimetics.

Ingram DK, Roth GS.

Exp Gerontol. 2011 Feb-Mar;46(2-3):148-54. doi: 10.1016/j.exger.2010.12.001. Epub 2010 Dec 15. Review.

PMID:
21167272
7.

Calorie restriction, SIRT1 and metabolism: understanding longevity.

Bordone L, Guarente L.

Nat Rev Mol Cell Biol. 2005 Apr;6(4):298-305. Review.

PMID:
15768047
8.

Calorie restriction mimetics: an emerging research field.

Ingram DK, Zhu M, Mamczarz J, Zou S, Lane MA, Roth GS, deCabo R.

Aging Cell. 2006 Apr;5(2):97-108. Review.

9.

Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction.

Haigis MC, Guarente LP.

Genes Dev. 2006 Nov 1;20(21):2913-21. Review.

10.

Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans.

Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC.

Annu Rev Med. 2003;54:131-52. Epub 2001 Dec 3. Review.

PMID:
12525670
11.

Sirtuins--novel therapeutic targets to treat age-associated diseases.

Lavu S, Boss O, Elliott PJ, Lambert PD.

Nat Rev Drug Discov. 2008 Oct;7(10):841-53. doi: 10.1038/nrd2665. Review. Erratum in: Nat Rev Drug Discov. 2009 Jun;8(6):516.

PMID:
18827827
12.

Neuronal protection by sirtuins in Alzheimer's disease.

Anekonda TS, Reddy PH.

J Neurochem. 2006 Jan;96(2):305-13. Epub 2005 Oct 7. Review.

13.

Neuroprotective signaling and the aging brain: take away my food and let me run.

Mattson MP.

Brain Res. 2000 Dec 15;886(1-2):47-53. Review.

PMID:
11119686
14.

Sirtuins in aging and age-related disease.

Longo VD, Kennedy BK.

Cell. 2006 Jul 28;126(2):257-68. Review.

15.

SIRT1 and neuronal diseases.

Tang BL, Chua CE.

Mol Aspects Med. 2008 Jun;29(3):187-200. Epub 2007 Feb 16. Review.

PMID:
17397914
16.

Sirtuins as possible drug targets in type 2 diabetes.

Kitada M, Kume S, Kanasaki K, Takeda-Watanabe A, Koya D.

Curr Drug Targets. 2013 Jun 1;14(6):622-36. Review.

PMID:
23445543
17.

Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.

Gan L.

Drug News Perspect. 2007 May;20(4):233-9. Review.

PMID:
17637936
18.

Calorie restriction and NAD⁺/sirtuin counteract the hallmarks of aging.

Michan S.

Front Biosci (Landmark Ed). 2014 Jun 1;19:1300-19. Review.

PMID:
24896352
19.

[Caloric restriction in primates: how efficient as an anti-aging approach?].

Marchal J, Perret M, Aujard F.

Med Sci (Paris). 2012 Dec;28(12):1081-6. doi: 10.1051/medsci/20122812018. Epub 2012 Dec 21. Review. French.

20.

Caloric restriction and brain function.

Gillette-Guyonnet S, Vellas B.

Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):686-92. doi: 10.1097/MCO.0b013e328313968f. Review.

PMID:
18827571

Supplemental Content

Support Center